Molecular damage in the bronchial epithelium of current and former smokers

Journal of the National Cancer Institute

Volumn 89, Issue 18, 1997, Pages 1366-1373

  Wistuba, Ignacio I ^a,b   Lam, Stephen ^d   Behrens, Carmen ^e   Virmani, Arvind K ^c   Fong, Kwun M ^e   LeRiche, Jean ^d   Samet, Jonathan M ^e   Srivastava, Sudhir ^f   Minna, John D ^c   Gazdar, Adi F ^a,c  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^b PONTIFICIA UNIVERSIDAD CATÓLICA DE CHILE   (Chile)

^c UNIVERSITY OF TEXAS   (United States)

^d BRITISH COLUMBIA CANCER AGENCY   (Canada)

^e JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^f NATIONAL CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; BRONCHOSCOPY; BRONCHUS BIOPSY; BRONCHUS MUCOSA; CIGARETTE SMOKING; FEMALE; HISTOLOGY; HUMAN; HUMAN TISSUE; LUNG CANCER; LUNG CARCINOGENESIS; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION;

EID: 0030846720     PISSN: 00278874     EISSN: None     Source Type: Journal    
DOI: 10.1093/jnci/89.18.1366     Document Type: Article

References (46)

1. Parker SL, Tong T, Bolden S, Wingo PA. Cancer statistics, 1996. CA Cancer J Clin 1996;46: 5-27.
2. Parkin DM, Pisani P, Lopez AD, Masuyer E. At least one in seven cases of cancer is caused by smoking. Global estimates for 1985. Int J Cancer 1994;5904:494-504.
3. Saccomanno G, Archer VE, Auerbach O, Saunders RP, Brennan LM. Development of carcinoma of the lung as reflected in exfoliated cells. Cancer 1974;33:256-70.
4. Auerbach O, Stout AP, Hammond EC, Garfinkel L. Changes in bronchial epithelium in relation to smoking and cancer of the lung. N Engl J Med 1961;265:253-67.
5. Auerbach O, Hammond EC, Garfinkel L. Changes in bronchial epithelium in relation to cigarette smoking, 1955-1960 vs. 1970-1977. N Engl J Med 1979;300:381-5.
6. Bertram JF, Rogers AW. Recovery of bronchial epithelium on stopping smoking. Br Med J (Clin Res Ed) 1981;283:1567-9.
7. U.S. Deparment of Health and Human Service. The health benefits of smoking cessation. Washington (DC): U.S. Department of Health and Human Services. Public Health Service, Centers for Disease Control. Center for Chronic Disease Prevention and Health Promotion. Office on Smoking and Health. 1990.
8. Schantz SP. Chemoprevention strategies: the relevance of premalignant and malignant lesions of the upper aerodigestive tract. J Cell Biochem Suppl 1993;17F:18-26.
9. Boone CW, Kelloff GJ. Intraepithelial neoplasia, surrogate endpoint biomarkers, and cancer chemoprevention. J Cell Biochem Suppl 1993;17F:37-48.
10. Gazdar AF, Bader S, Hung J, Kishimoto Y, Sekido Y, Sugio K, et al. Molecular genetic changes found in human lung cancer and its precursor lesions. Cold Spring Harb Symp Quant Biol 1994;59:565-72.
11. Minna JD, Sekido Y, Fong K, Gazdar AF. Molecular biology of lung cancer, chapt 30.1. In: DeVita VT Jr, Hellman S, Rosenberg SA, editors. Cancer: principles and practice of oncology, 5th ed. Philadelphia: Lippincott, 1997: 849-57.
12. Sugio K, Kishimoto Y, Virmani AK, Hung JY, Gazdar AF. K-ras mutations are a relatively late event in the pathogenesis of lung carcinomas. Cancer Res 1994;54:5811-5.
13. Hung J, Kishimoto Y, Sugio K, Virmani A, McIntire DD, Minna JD, et al. Allele-specific chromosome 3p deletions occur at an early stage in the pathogenesis of lung carcinoma [published erratum appears in JAMA 1995; 273:1908]. JAMA 1995;273:558-63.
14. Kishimoto Y, Sugio K, Hung JY, Virmani AK, McIntire DD, Minna JD, et al. Allele-specific loss in chromosome 9p loci in preneoplastic lesions accompanying non-small-cell lung cancers. J Natl Cancer Inst 1995;87:1224-9.
15. Sundaresan V, Ganly P, Hasleton P, Rudd R, Sinha G, Bleehen NM, et al. p53 and chromosome 3 abnormalities, characteristic of malignant lung tumours, are detectable in preinvasive lesions of the bronchus. Oncogene 1992; 7:1989-97.
16. Thiberville L, Payne P, Vielkinds J, LeRiche J, Horsman D, Nouvet G, et al. Evidence of cumulative gene losses with progression of premalignant epithelial lesions to carcinoma of the bronchus. Cancer Res 1995;55:5133-9.
17. Chung GT, Sundaresan V, Hasleton P, Rudd R, Taylor R, Rabbitts PH. Clonal evolution of lung tumors. Cancer Res 1996;56:1609-14.
18. Smith AL, Hung J, Walker L, Rogers TE, Vuitch F, Lee E, et al. Extensive areas of aneuploidy are present in the respiratory epithelium of lung cancer patients. Br J Cancer 1996; 73:203-9.
19. Mao L, Lee DJ, Tockman MS, Erozan YS, Askin F, Sidransky D. Microsatellite alterations as clonal markers for the detection of human cancer. Proc Natl Acad Sci U S A 1994; 91:9871-5.
20. Miozzo M, Sozzi G, Musso K, Pilotti S, Incarbone M, Pastorino U, et al. Microsatellite alterations in bronchial and sputum specimens of lung cancer patients. Cancer Res 1996;56: 2285-8.
21. Fong KM, Zimmerman PV, Smith PJ. Microsatellite instability and other molecular abnormalities in non-small cell lung cancer. Cancer Res 1995;55:28-30.
22. Adachi J. Shiseki M. Okazaki T. Ishimaru G. Noguchi M. Hirohashi S. et al. Microsatellite instability in primary and metastatic lung carcinomas. Genes Chromosomes Cancer 1995; 14:301-6.
23. Merlo A, Mabry M, Gabrielson E, Vollmer R, Baylin SB, Sidransky D. Frequent microsateliite instability in primary small cell lung cancer. Cancer Res 1994;54:2098-101.
24. Fishel R, Lescoe MK, Rao MR, Copeland NG, Jenkins NA, Garber J, et al. The human mutator gene homolog MSH2 and its association with hereditary nonpolyposis colon cancer [published erratum appears in Cell 1994:77: 167]. Cell 1993;75:1027-38.
25. Mao L, Lee JS, Kurie JM, Fan YH, Lippman SM, Lee JJ, et al. Clonal genetic alterations in the lungs of current and former smokers. J Natl Cancer Inst 1997;89:857-62.
26. Lam S, MacAulay C, Hung J, LeRiche J, Profio AE, Palcic B, et al. Detection of dysplasia and carcinoma in situ with a lung imaging fluorescence endoscope device. J Thorac Cardiovasc Surg 1993;105:1035-40.
27. Lam S, MacAulay C, LeRiche JC, Ikeda N, Palcic B. Early localization of bronchogenic carcinoma. Diagnos Therapeut Endos 1994;1: 75-8.
28. Cawkwell L, Lewis FA, Quirke P. Frequency of allele loss of DCC, p53, RBI, WT1, NF1, NM23 and APC/MCC in colorectal cancer assayed by fluorescent multiplex polymerase chain reaction. Br J Cancer 1994;70: 813-8.
29. Jones MH, Nakamura Y. Detection of loss of heterozygosity at the human TP53 locus using a dinucleotide repeat polymorphism. Genes Chromosomes Cancer 1992;5:89-90.
30. Toguchida J, McGee TL, Paterson JC, Eagle JR, Tucker S, Yandell DW, et al. Complete genomic sequence of the human retinoblastoma susceptibility gene. Genomics 1993;17: 535-43.
31. Armitage P, Berry G. Statistical methods in medical research. Palo Alto (CA): Blackwell Scientific Publications, 1987.
32. Siegel S. Nonparametric statistics for the behavioral sciences. New York: McGraw-Hill, 1956.
33. Anon: Office of Smoking and Health, U.S. Centers for Disease Control. Morbidity and Mortality Weekly Report 43, 1994.
34. Tong L, Spitz MR, Fueger JJ, Amos CA. Lung carcinoma in former smokers. Cancer 1996;78: 1004-10.
35. Slaughter DP, Southwick HW, Smejkal W. "Field cancerization" in oral stratified squamous epithelium: clinical implications of multicentric origin. Cancer 1954;6:963-8.
36. Heyne KH, Lippman SM, Lee JJ, Lee JS, Hong WK. The incidence of second primary tumors in long-term survivors of small-cell lung cancer. J Clin Oncol 1992;10:1519-24.
37. Noguchi M, Maezawa N, Nakanishi Y, Matsuno Y, Shimosato Y, Hirohashi S. Application of the p53 gene mutation pattern for differential diagnosis of primary versus metastatic lung carcinomas. Diagn Mol Pathol 1993;2: 29-35.
38. Johnson BE, Linnoila RI, Williams JP, Venzon DJ, Okunieff P, Anderson GB, et al. Risk of second aerodigestive cancers increases in patients who survive free of small-cell lung cancer for more than 2 years. J Clin Oncol 1995; 13:101-11.
39. Fisher JC. Multiple mutation theory of carcinogenesis. Nature 1958;181:651-2.
40. Loeb LA. Mutator phenotype may be required for multistage carcinogenesis. Cancer Res 1991;51:3075-9.
41. Loeb LA. Microsatellite instability: marker of a mutator phenotype in cancer. Cancer Res 1994;54:5059-63.
42. O'Connell P, Pekkel V, Fuqua S, Osborne CK, Allred DC. Molecular genetic studies of early breast cancer evolution. Breast Cancer Res Treat 1994;32:5-12.
43. Wright TC, Kurman RJ, Ferenczy A. Precancerous lesions of the cervix. In: Kurman RJ, editor. Blaustein's pathology of the female genital tract. New York: Springer-Verlag, 1994:229-77.
44. Fearon ER. Molecular genetic studies of the adenoma-carcinoma sequence. Adv Intern Med 1994;39:123-47.
45. D'Amico D, Carbone DP, Johnson BE, Meltzer SJ, Minna JD. Polymorphic sites within the MCC and APC loci reveal very frequent loss of heterozygosity in human small cell lung cancer. Cancer Res 1992;52:1996-9.
46. Wieland I, Bohm M. Frequent allelic deletion at a novel locus on chromosome 5 in human lung cancer. Cancer Res 1994;54:1772-4.